Page last updated: 2024-08-22

trolamine salicylate and Progeria

trolamine salicylate has been researched along with Progeria in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnold, R; Djabali, K; Henriques, G; Liu, C	1

Other Studies

1 other study(ies) available for trolamine salicylate and Progeria

Article	Year
Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells. Cells, 2019, 10-18, Volume: 8, Issue:10 Topics: Adenosine Triphosphate; Alopecia; Arthritis; Autophagy; Azetidines; Blotting, Western; Cell Cycle; Cells, Cultured; Cellular Senescence; Child; Child, Preschool; Data Mining; Etoposide; Female; Humans; Immunohistochemistry; Inflammation; Janus Kinase 1; Janus Kinase 2; Lamin Type A; Lipodystrophy; Male; Mutation; Progeria; Purines; Pyrazoles; Reactive Oxygen Species; STAT1 Transcription Factor; STAT3 Transcription Factor; Sulfonamides; Vascular Diseases	2019

Article

Year

Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells.

Cells, 2019, 10-18, Volume: 8, Issue:10

Topics: Adenosine Triphosphate; Alopecia; Arthritis; Autophagy; Azetidines; Blotting, Western; Cell Cycle; Cells, Cultured; Cellular Senescence; Child; Child, Preschool; Data Mining; Etoposide; Female; Humans; Immunohistochemistry; Inflammation; Janus Kinase 1; Janus Kinase 2; Lamin Type A; Lipodystrophy; Male; Mutation; Progeria; Purines; Pyrazoles; Reactive Oxygen Species; STAT1 Transcription Factor; STAT3 Transcription Factor; Sulfonamides; Vascular Diseases

2019